Skip to content

The skin improvement effect of two skin cream products

Product A (test product), product B (control product) evaluation of human efficacy for skin moisturization and wrinkle improvement

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN77018521
Enrollment
22
Registered
2023-05-11
Start date
2021-10-01
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry skin Skin and Connective Tissue Diseases

Interventions

The cream was made in two types, one was the A cream and the other was a placebo (dummy cream) for estimating the effects of plant extract. All participants put on this cream two times per day for 4 w

Sponsors

COSMAX
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Females with dried skin, aged 30-59 years 2. The subject has eye wrinkles (crow’s feet) 3. A person who has voluntarily signed consent after fully explaining the test purpose and content 4. Those who can follow up during the test period 5. A healthy person without acute or chronic physical disease including skin disease

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating women and women of childbearing age who do not agree to the contraceptive method prescribed by the protocol 2. A person with a lesion at the test site or suffering from an infectious skin disease 3. People with allergies or hypersensitivity, or irritation to cosmetics, pharmaceuticals, or daily exposure to light 4. Those who have received systemic steroids or phototherapy within 1 month of participating in the trial, or who have received skin treatment (scaling/botox/filler/laser/tattoo) within 3 months of participating in the trial 5. Those who have used drugs with similar functions at the research site within 3 months before the start of the study, or have a mental illness, or mental retardation disorder 6. Other than the above, a person who will make it difficult to conduct a human test based on the judgment of the responsible researcher or the person in charge of the study

Design outcomes

Primary

MeasureTime frame
The skin wrinkle is measured using a visual assessment using an Antera 3D CS (Miravex, Ireland) at baseline, 0, 2, and 4 weeks. The skin moisture level was conducted using a Corneometer CM825 (Courage and Khazaka, Köln, Germany) at baseline, 0, 2, and 4 weeks.

Secondary

MeasureTime frame
The skin wrinkle is measured using a visual assessment using an Antera 3D CS (Miravex, Ireland) at baseline, 0, 2, and 4 weeks. The skin moisture level was conducted using a Corneometer CM825 (Courage and Khazaka, Köln, Germany) at baseline, 0, 2, and 4 weeks.

Countries

Korea, South

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026